DeepMed Research

THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

Vitamin Therapy in Concussion Management: A Randomized Control Trial

Not Applicable

Terminated

Conditions: Concussion

Interventions: Dietary Supplement: Placebo

First Posted Date: 2015-03-09

Last Posted Date: 2022-04-13

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT02382679

Umbilical Cord Milking for Neonates With Hypoxic Ischemic Encephalopathy

Not Applicable

Completed

Conditions: Umbilical Cord Milking
Hypoxic Ischemic Encephalopathy

Interventions: Procedure: Umbilical Cord Milking

First Posted Date: 2014-11-10

Last Posted Date: 2017-12-18

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 101

Registration Number: NCT02287077

Locations: 🇮🇳
Lata Mangeshkar Hospital and NKP Salve Institute of Medical Sciences, Nagpur, MS, India

Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients

Not Applicable

Completed

Conditions: Colorectal Cancer

Interventions: Behavioral: Standard
Behavioral: Decision Support & Navigation

First Posted Date: 2014-10-22

Last Posted Date: 2025-05-04

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 400

Registration Number: NCT02272244

Locations: 🇺🇸
Lehigh Valley Hospital, Allentown, Pennsylvania, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study

Early Phase 1

Terminated

Conditions: Dermatomyositis

Interventions: Drug: Immunoglobulin (Hizentra)

First Posted Date: 2014-10-22

Last Posted Date: 2018-05-16

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 2

Registration Number: NCT02271165

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

Phase 1

Completed

Conditions: Thrombosis

Interventions: Drug: Kcentra
Drug: Apixaban
Drug: Placebo

First Posted Date: 2014-10-21

Last Posted Date: 2016-06-07

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 12

Registration Number: NCT02270918

Locations: 🇺🇸
Thomas Jefferson University Hosptial, Philadelphia, Pennsylvania, United States

Improving Medication Adherence in Older African Americans With Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes
Mild Cognitive Impairment

Interventions: Behavioral: Primary Care-Occupational Therapy
Behavioral: Enhanced Usual Care

First Posted Date: 2014-06-25

Last Posted Date: 2020-08-10

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 101

Registration Number: NCT02174562

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients

Completed

Conditions: Systolic Heart Failure

First Posted Date: 2014-06-05

Last Posted Date: 2018-04-10

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT02156583

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Collaborative Care for Depression and Diabetic Retinopathy in African Americans

Not Applicable

Completed

Conditions: Diabetic Retinopathy

Interventions: Behavioral: Behavioral Activation

First Posted Date: 2014-04-23

Last Posted Date: 2019-02-21

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 40

Registration Number: NCT02121340

Locations: 🇺🇸
Wills Eye Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Randomized Control Trial of Second Stage of Labor

Not Applicable

Completed

Conditions: Labor Complications

Interventions: Other: Length of Second Stage

First Posted Date: 2014-04-02

Last Posted Date: 2018-10-26

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 78

Registration Number: NCT02101515

Locations: 🇺🇸
Thomas Jefferson University Hosptial, Philadelphia, Pennsylvania, United States

Incobotulinum Toxin for the Treatment of Trigeminal Neuralgia

Phase 2

Terminated

Conditions: Trigeminal Neuralgia

Interventions: Other: Placebo Comparator
Biological: Incobotulinumtoxina

First Posted Date: 2014-03-17

Last Posted Date: 2023-06-28

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 6

Registration Number: NCT02088632

Locations: 🇺🇸
Jefferson Headache Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy